CTRI/2021/08/035875尚未招募3 期
An Open Label Single Arm Study to Evaluate the Effect of Shephalika Patra Kwatha and Gandharva Hastadi Taila in the Management of Gridhrasi vis-a-vis (Sciatica) - NI
Dr PALKI BORUAH0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Subjects of either gender in between the age group of 20-60 years
- •Subjects presenting with Lakshanas of Gridhrasi
- •Subjects presenting with signs and Subjects symptoms of Sciatica
- •Post Covid and Non Covid Subjects
排除标准
- •Subjects with systemic disorders that may interfere with the course of treatment
- •Subjects with history of spinal fracture Neoplastic condition of spine Infections like Tuberculosis etc
- •Pregnant and lactating mother
研究者
相似试验
尚未招募
Unknown
Marma therapy in sleeplessnessCTRI/2024/07/071601Dr Arya P
已完成
1 期
To evaluate The Effect Of Murvadya Choorna Vati In Pandu Vyadhi (Iron Deficiency Anaemia�)CTRI/2018/02/012256Self60
招募中
1 期
An open label, single arm study to evaluate single and multiple dose pharmacokinetics, safety and tolerability, and to explore clinical outcomes of treatment with intravenous (IV) zanamivir in neonates and infants under 6 months of age with confirmed complicated influenza infection.CTIS2024-510663-34-00Glaxosmithkline Research & Development Limited12
进行中（未招募）
1 期
An open label, single arm study to evaluate the pharmacokinetics, safety and tolerability of intravenous (IV) zanamivir in hospitalised neonates and infants under 6 months of age with confirmed influenza infectioInfluenzaEUCTR2019-001588-63-NLGlaxoSmithKline Research & Development Limited12
进行中（未招募）
1 期
An open label, single arm study to evaluate the pharmacokinetics, safety and tolerability of intravenous (IV) zanamivir in hospitalised neonates and infants under 6 months of age with confirmed influenza infectioInfluenzaEUCTR2019-001588-63-PLGlaxoSmithKline Research & Development Limited12